The Latest Cardiac and Vascular News
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a prospective, multicenter, single-arm, clinical study of the TRIA™ mitral surgical heart valve with LifePolymer™ conducted in India. At […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have surpassed 200 patient life years in human recipients. Patient life years represent the cumulative time the valve has […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc., a pioneer in the development of innovative, polymer heart valves, today announced a manufacturing agreement with Dolphin Life Science India LLP to enable in-country manufacturing of the TRIA™ polymer mitral surgical heart valve outside of the […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial of the TRIA™ surgical mitral heart […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc. today announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a polymer technology patent family. Foldax has incorporated the polymer technology into its LifePolymer™ materials platform and has conducted […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday. In his more than 30 years in the medical technology arena, Mr. Casciaro has developed a […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ biopolymer surgical aortic heart valve. The TRIA valve reimagines the heart valve by […]
Data Presented at Cardiovascular Research Technologies (CRT) Annual Conference SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced the presentation of results from the first animal study of its transcatheter valve from the TRIA™ biopolymer heart valve portfolio this past weekend at […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced the appointment of medical device veteran Scott Huennekens as an independent member of the company’s board of directors. Huennekens possesses more than 30 years of experience in the medical device industry, leading high-profile […]
Publication in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions Found TRIA Aortic Heart Valve Provided Sustained Improvement in Heart Valve Function to One-Year with Good Safety Profile SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced publication of the […]
